Clinical Trials Directory

Trials / Conditions / NSCLC, Stage IIIA

NSCLC, Stage IIIA

7 registered clinical trials studyying NSCLC, Stage IIIA — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNeoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lun
NCT06614231
Sun Yat-sen UniversityPhase 2
UnknownA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver Mutations
NCT05157776
Tongji UniversityPhase 3
RecruitingPredicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSC
NCT04865250
University Hospital HeidelbergPhase 2
WithdrawnImmunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
NCT03628144
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
RecruitingNeoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
NCT04205552
University Hospital, EssenPhase 2
CompletedMetabolomics Predict Therapy Response
NCT03736993
Hasselt UniversityN/A
UnknownNeoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations
NCT01470716
National Cancer Center, KoreaPhase 2